IN2014DN08089A - - Google Patents
Info
- Publication number
- IN2014DN08089A IN2014DN08089A IN8089DEN2014A IN2014DN08089A IN 2014DN08089 A IN2014DN08089 A IN 2014DN08089A IN 8089DEN2014 A IN8089DEN2014 A IN 8089DEN2014A IN 2014DN08089 A IN2014DN08089 A IN 2014DN08089A
- Authority
- IN
- India
- Prior art keywords
- fatty acids
- fish oil
- progestogen
- dha
- epa
- Prior art date
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 2
- 235000021323 fish oil Nutrition 0.000 abstract 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a hormone containing oil in water emulsion for parenteral administration comprising a) progestogen and/or estrogen and b) fish oil triglycerides wherein the fish oil triglyceride consists of glycerol which is esterified with fatty acids wherein said fatty acids comprise eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in an amount of at least 45 % by weight of said fatty acids.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12157546 | 2012-02-29 | ||
| PCT/EP2013/053686 WO2013127728A1 (en) | 2012-02-29 | 2013-02-25 | Hormone containing emulsion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08089A true IN2014DN08089A (en) | 2015-05-01 |
Family
ID=47748635
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8089DEN2014 IN2014DN08089A (en) | 2012-02-29 | 2013-02-25 | |
| IN8088DEN2014 IN2014DN08088A (en) | 2012-02-29 | 2013-02-25 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8088DEN2014 IN2014DN08088A (en) | 2012-02-29 | 2013-02-25 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20150018320A1 (en) |
| EP (2) | EP2819649B1 (en) |
| JP (2) | JP2015508791A (en) |
| KR (2) | KR20140131936A (en) |
| CN (3) | CN104136008A (en) |
| BR (2) | BR112014021390A2 (en) |
| CA (2) | CA2865030C (en) |
| ES (1) | ES2659466T3 (en) |
| IL (2) | IL233759B (en) |
| IN (2) | IN2014DN08089A (en) |
| MX (2) | MX356427B (en) |
| NO (1) | NO2819649T3 (en) |
| PL (1) | PL2819649T3 (en) |
| PT (1) | PT2819649T (en) |
| RU (2) | RU2014139008A (en) |
| WO (2) | WO2013127728A1 (en) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8633178B2 (en) | 2011-11-23 | 2014-01-21 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| WO2014057522A1 (en) | 2012-10-12 | 2014-04-17 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10441560B2 (en) | 2013-03-15 | 2019-10-15 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| KR20150127599A (en) | 2013-03-15 | 2015-11-17 | 모치다 세이야쿠 가부시키가이샤 | Compositions and methods for treating non-alcoholic steatohepatitis |
| KR101588247B1 (en) | 2013-04-17 | 2016-01-25 | 경희대학교 산학협력단 | Composition for preventing or treating stroke or degenerative brain disease |
| EP3054940B1 (en) * | 2013-10-07 | 2020-09-23 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| GB201402450D0 (en) | 2014-02-12 | 2014-03-26 | Aker Biomarine As | Liquid phospholipid-containing compositions for preperation of pharmaceuticals |
| GB201402457D0 (en) | 2014-02-12 | 2014-03-26 | Aker Biomarine As | Capsules containing high doses of phospholipids |
| GB201407345D0 (en) | 2014-04-25 | 2014-06-11 | Aker Biomarine As | Krill Phospholipid compositions |
| CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| RU2016141135A (en) | 2014-07-29 | 2018-08-28 | Терапьютиксмд, Инк. | TRANSDERMAL CREAM |
| EP3232798A1 (en) | 2014-12-19 | 2017-10-25 | Aker Biomarine Antarctic AS | Enhanced omega-3 formulations |
| WO2016156528A1 (en) * | 2015-03-31 | 2016-10-06 | Fresenius Kabi Deutschland Gmbh | Emulsions for parenteral administration |
| GB201509606D0 (en) * | 2015-06-03 | 2015-07-15 | Anabio Technologies Ltd | Microencapsulates containing stabilised marine-derived oil, and methods for production thereof |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| CN105878184A (en) * | 2016-04-26 | 2016-08-24 | 天津市中升挑战生物科技有限公司 | Altrenogest nanometer emulsion and method for preparing same |
| PL3664628T3 (en) * | 2017-08-10 | 2025-04-07 | The Children's Medical Center Corporation | Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids |
| WO2021123117A1 (en) | 2019-12-20 | 2021-06-24 | Fresenius Kabi Austria Gmbh | Method for producing oil-in-water emulsions |
| US20230190693A1 (en) * | 2020-04-15 | 2023-06-22 | The Trustees Of Columbia University In The City Of New York | Stable diglyceride emulsions and methods for treating organ injury |
| US20240050391A1 (en) * | 2020-12-07 | 2024-02-15 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for neuroprotection in neonatal hypoxic-ischemic encephalopathy |
| GB202316026D0 (en) * | 2023-10-19 | 2023-12-06 | Theramex Hq Uk Ltd | Methods of prevention or treatment |
| WO2025083197A1 (en) * | 2023-10-20 | 2025-04-24 | Sativari UG (haftungsbeschränkt) | Liquid pharmaceutical formula for intravenous, subcutaneous or intramuscular application of one or more cannabinoids |
| DE102023128848A1 (en) * | 2023-10-20 | 2025-04-24 | Sativari UG (haftungsbeschränkt) | Liquid pharmaceutical formulation for intravenous, subcutaneous, or intramuscular administration of one or more cannabinoids |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2738253A1 (en) | 1977-08-25 | 1979-03-01 | Dabisch Tipp Ex Tech | BODY WITH REVERSIBLE TEMPERATURE-DEPENDENT TRANSPARENCY |
| DE2749265A1 (en) | 1977-11-03 | 1979-05-10 | Linde Ag | METHOD FOR BIOLOGICAL WASTE WATER TREATMENT |
| JPS60258110A (en) | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | Progesterone emulsified parenteral solution injectable intravenously |
| US5560364A (en) | 1995-05-12 | 1996-10-01 | The Board Of Regents Of The University Of Nebraska | Suspended ultra-sound induced microbubble cavitation imaging |
| US20100173876A1 (en) * | 2000-12-19 | 2010-07-08 | The Board Of Regents Of The University Of Texas System | Oil-based nsaid compositions and methods for making and using same |
| US8729124B2 (en) | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
| EP1488785A1 (en) * | 2003-06-18 | 2004-12-22 | B. Braun Melsungen Ag | Oil emulsion for postnatal substitution of hormones |
| IL158552A0 (en) * | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Lipids containing omega-3 fatty acids |
| US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
| PT1868614E (en) | 2005-03-24 | 2012-11-23 | Univ Emory | Dosage regimen for the treatment of a traumatic brain injury with progesterone |
| CN103211807A (en) * | 2005-07-08 | 2013-07-24 | Dsmip资产公司 | Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
| CA2631497C (en) * | 2005-12-05 | 2014-04-22 | Bioartificial Gel Technologies Inc. | Emulsions of a protein-crosslinked hydrogel matrix and dispersed hydrophobic phase |
| WO2007080515A1 (en) | 2006-01-13 | 2007-07-19 | Aker Biomarine Asa | Thrombosis preventing krill extract |
| JP5352961B2 (en) * | 2006-03-28 | 2013-11-27 | Ｊｎｃ株式会社 | Life-style related diseases prevention / treatment agents |
| CN101152186B (en) | 2007-09-05 | 2011-07-06 | 杭州平和安康医药科技有限公司 | Progesterone injection and method for preparing the same |
| US8241672B2 (en) * | 2009-03-11 | 2012-08-14 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| RU2009145010A (en) | 2009-12-04 | 2011-06-20 | Общество с ограниченной ответственностью (ООО) "Аббифарм" (RU) | COMPOSITION OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACIDS |
| TW201138782A (en) * | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| US8895074B2 (en) * | 2011-06-15 | 2014-11-25 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
| CN102277237B (en) * | 2011-06-20 | 2013-04-24 | 山东禹王制药有限公司 | Preparation method of high-purity glyceride type fish oil |
-
2013
- 2013-02-25 JP JP2014559164A patent/JP2015508791A/en active Pending
- 2013-02-25 PL PL13705798T patent/PL2819649T3/en unknown
- 2013-02-25 US US14/379,500 patent/US20150018320A1/en not_active Abandoned
- 2013-02-25 CN CN201380011584.6A patent/CN104136008A/en active Pending
- 2013-02-25 KR KR1020147024144A patent/KR20140131936A/en not_active Withdrawn
- 2013-02-25 KR KR1020147024150A patent/KR102027613B1/en not_active Expired - Fee Related
- 2013-02-25 US US14/379,505 patent/US9789122B2/en not_active Expired - Fee Related
- 2013-02-25 WO PCT/EP2013/053686 patent/WO2013127728A1/en not_active Ceased
- 2013-02-25 MX MX2014010442A patent/MX356427B/en active IP Right Grant
- 2013-02-25 CA CA2865030A patent/CA2865030C/en active Active
- 2013-02-25 CN CN201910525844.0A patent/CN110251463A/en active Pending
- 2013-02-25 BR BR112014021390A patent/BR112014021390A2/en not_active IP Right Cessation
- 2013-02-25 MX MX2014010445A patent/MX2014010445A/en unknown
- 2013-02-25 CN CN201380010731.8A patent/CN104136007A/en active Pending
- 2013-02-25 WO PCT/EP2013/053679 patent/WO2013127727A1/en not_active Ceased
- 2013-02-25 ES ES13705798.0T patent/ES2659466T3/en active Active
- 2013-02-25 RU RU2014139008A patent/RU2014139008A/en unknown
- 2013-02-25 BR BR112014021391-7A patent/BR112014021391B1/en not_active IP Right Cessation
- 2013-02-25 NO NO13705798A patent/NO2819649T3/no unknown
- 2013-02-25 EP EP13705798.0A patent/EP2819649B1/en active Active
- 2013-02-25 PT PT137057980T patent/PT2819649T/en unknown
- 2013-02-25 EP EP13706965.4A patent/EP2819650A1/en not_active Withdrawn
- 2013-02-25 RU RU2014138996A patent/RU2678319C2/en active
- 2013-02-25 CA CA2864945A patent/CA2864945A1/en not_active Abandoned
- 2013-02-25 IN IN8089DEN2014 patent/IN2014DN08089A/en unknown
- 2013-02-25 JP JP2014559165A patent/JP6169110B2/en not_active Expired - Fee Related
- 2013-02-25 IN IN8088DEN2014 patent/IN2014DN08088A/en unknown
-
2014
- 2014-07-23 IL IL233759A patent/IL233759B/en active IP Right Grant
- 2014-07-23 IL IL233760A patent/IL233760A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN08089A (en) | ||
| MX2011009507A (en) | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions. | |
| NZ721036A (en) | Lipid comprising long chain polyunsaturated fatty acids | |
| NZ626699A (en) | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | |
| MX349678B (en) | PRODUCTION OF LONG CHAIN POLYINSATURATED FATTY ACIDS IN VEGETABLE CELLS. | |
| HRP20200065T1 (en) | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia | |
| PH12014500105A1 (en) | Fatty acid compositions | |
| NZ709083A (en) | Eicosapentaenoic acid (epa) formulations | |
| NZ595599A (en) | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof | |
| FR2955459B1 (en) | OIL COMPOSITION RICH IN MONOGLYCERIDES OF DHA | |
| NZ716730A (en) | Methods, compositions, and devices for supplying dietary fatty acid needs | |
| TW201613488A (en) | Nutritional compositions containing oil blends and uses thereof | |
| RU2015148149A (en) | CHILD MIXTURE WITH A LOW CONTENT OF MCFA IN CERTAIN PROPORTIONS AND RELATIVELY A HIGH CONTENT OF FATTY ACIDS AND ITS APPLICATION IN STIMULATION OF HEALTHY BECOMING OF COGNITIVE FUNCTION IN CHILDREN | |
| UA111967C2 (en) | HEALTHY FOOD PRODUCT CONTAINING FATTY FATTY ACIDS AND FATTING METHOD | |
| BR112014013593A2 (en) | dha retention during canola oil processing | |
| EA201591680A1 (en) | FATTY ACID MIXTURE (GLS, FATTY ACIDS GROUP) AND ITS APPLICATION FOR THE TREATMENT OF INFLAMMATORY PATHOLOGIES | |
| HRP20171431T1 (en) | THERAPY PARENTERAL APPLICATION OF WING OIL | |
| PE20251289A1 (en) | COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS ENRICHED WITH DHA | |
| JP2016501248A5 (en) | ||
| RU2016116835A (en) | METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION | |
| WO2012153345A9 (en) | Docosahexaenoic acid (dha) as polyunsaturated free fatty acid in its directly compressible powder form and method of isolation thereof | |
| MX2022005627A (en) | Lipid comprising docosapentaenoic acid. | |
| MX358743B (en) | Non-oleic triglyceride based, low viscosity, high flash point dielectric fluids. | |
| WO2014137894A3 (en) | Production of omega-3 fatty acids from pythium species | |
| Dias et al. | Kinetics of omega-3 polyunsaturated fatty acids when co-administered with saturated or omega-6 fats |